BioCentury
ARTICLE | Company News

Nexell, Baxter Healthcare Corp. gene/cell therapy news

October 21, 2002 7:00 AM UTC

NEXL said it would distribute $0.05 per share to all common stockholders, except BAX as part of a plan to liquidate its business. BAX and its affiliates, the sole preferred stockholders, will receive ...